204 related articles for article (PubMed ID: 38365970)
1. Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer.
Xu T; Verhagen MP; Teeuwssen M; Sun W; Joosten R; Sacchetti A; Ewing-Graham PC; Jansen MPHM; Boere IA; Bryce NS; Zeng J; Treutlein HR; Hook J; Hardeman EC; Gunning PW; Fodde R
Cell Death Differ; 2024 Mar; 31(3):360-377. PubMed ID: 38365970
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer.
Xu T; Verhagen M; Joosten R; Sun W; Sacchetti A; Munoz Sagredo L; Orian-Rousseau V; Fodde R
Elife; 2022 Nov; 11():. PubMed ID: 36346211
[TBL] [Abstract][Full Text] [Related]
3. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer.
Sacchetti A; Teeuwssen M; Verhagen M; Joosten R; Xu T; Stabile R; van der Steen B; Watson MM; Gusinac A; Kim WK; Ubink I; Van de Werken HJ; Fumagalli A; Paauwe M; Van Rheenen J; Sansom OJ; Kranenburg O; Fodde R
Elife; 2021 May; 10():. PubMed ID: 34036938
[TBL] [Abstract][Full Text] [Related]
5. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
6. Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines.
Varankar SS; More M; Abraham A; Pansare K; Kumar B; Narayanan NJ; Jolly MK; Mali AM; Bapat SA
Carcinogenesis; 2020 Jun; 41(4):515-526. PubMed ID: 31241128
[TBL] [Abstract][Full Text] [Related]
7. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
[TBL] [Abstract][Full Text] [Related]
8. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
[TBL] [Abstract][Full Text] [Related]
9. The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells.
Ford CE; Jary E; Ma SS; Nixdorf S; Heinzelmann-Schwarz VA; Ward RL
PLoS One; 2013; 8(1):e54362. PubMed ID: 23326605
[TBL] [Abstract][Full Text] [Related]
10. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
[TBL] [Abstract][Full Text] [Related]
11. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y
Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316
[TBL] [Abstract][Full Text] [Related]
12. Epithelial/mesenchymal heterogeneity of high-grade serous ovarian carcinoma samples correlates with miRNA let-7 levels and predicts tumor growth and metastasis.
Chirshev E; Hojo N; Bertucci A; Sanderman L; Nguyen A; Wang H; Suzuki T; Brito E; Martinez SR; Castañón C; Mirshahidi S; Vazquez ME; Wat P; Oberg KC; Ioffe YJ; Unternaehrer JJ
Mol Oncol; 2020 Nov; 14(11):2796-2813. PubMed ID: 32652647
[TBL] [Abstract][Full Text] [Related]
13. Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis.
Primeaux M; Gowrikumar S; Dhawan P
Clin Exp Metastasis; 2022 Jun; 39(3):391-406. PubMed ID: 35023031
[TBL] [Abstract][Full Text] [Related]
14. Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition.
Zhu LY; Zhang WM; Yang XM; Cui L; Li J; Zhang YL; Wang YH; Ao JP; Ma MZ; Lu H; Ren Y; Xu SH; Yang GD; Song WW; Wang JH; Zhang XD; Zhang R; Zhang ZG
Cancer Lett; 2015 Jul; 363(1):71-82. PubMed ID: 25864591
[TBL] [Abstract][Full Text] [Related]
15. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
16. The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival.
Rae S; Spillane C; Blackshields G; Madden SF; Keenan J; Stordal B
Hum Cell; 2022 Sep; 35(5):1547-1559. PubMed ID: 35794446
[TBL] [Abstract][Full Text] [Related]
17. Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer.
Esquer H; Zhou Q; Nemkov T; Abraham AD; Rinaldetti S; Chen YC; Zhang X; Orman MV; D'Alessandro A; Ferrer M; Messersmith WA; LaBarbera DV
Oncogene; 2021 Apr; 40(16):2884-2897. PubMed ID: 33742123
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
[TBL] [Abstract][Full Text] [Related]
19. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
[TBL] [Abstract][Full Text] [Related]
20. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
